FDA Orange Book · active-ingredient family
Phentermine resin complex
Phentermine resin complex is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:IONAMIN · NDA 011613
1
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| IONAMIN×2 | UCB INC | NDA 011613 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PHENTERMINE RESIN COMPLEX×2 | LANNETT CO INC | ANDA 040872 | — | Jul 28, 2011 | |
| PHENTERMINE RESIN 30 | QUANTUM PHARMICS | ANDA 089120 | — | Feb 04, 1988 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Phentermine resin complex — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
